Skip to main content
. 2017 Mar 11;8(45):79137–79146. doi: 10.18632/oncotarget.16134

Table 2. In-hospital data on admission of study groups.

Variable Female arm (N = 169) (32.8%) Male arm (N = 346) (67.2%) CTO (+) (N = 226)
CTO(+) N = 74 (43.8%) CTO(-) N = 95 (56.2%) P CTO(+) N = 152 (43.9%) CTO(-) N = 194 (56.1%) P Female vs Male
P
Chest pain, % 95.9 89.5 0.12 92.0 93.8 0.51 0.27
Killip class III, % 8.1 7.4 0.86 6.6 2.6 0.07 0.68
Killip class IV, % 4.0 2.1 0.46 0.7 1.0 0.71 0.070
Heart rate, bpm ± SD 82 ± 22 81 ± 15 0.75 82 ± 17 76 ± 15 0.0005 0.89
SBP, mmHg ± SD 148 ± 34 152 ± 29 0.39 148 ± 29 151 ± 29 0.44 0.95
DBP, mmHg ± SD 85 ± 21 86 ± 19 0.66 90 ± 17 89 ± 18 0.76 0.077
BMI, kg/m2 (Q1-Q3) 29 (24-31) 29 (26-31) 0.69 27 (25-30) 28 (25-30) 0.96 0.50
WBC, tys/uL (Q1-Q3) 10 (8-13) 10 (8-12) 0.87 10 (8-12 9 (7-11) 0.01 0.39
Hemoglobin, mmol/L ± SD 8.0 ± 0.9 7.9 ± 1.1 0.28 8.8 ± 1.1 8.7 ± 1.0 0.44 <0.0001
Glucose, mmol/L (Q1-Q3) 7.4 (5.9-12.4) 7.9 (6.1-10.8) 0.23 6.6 (5.6-8.3) 6.2 (5.5-7.7) 0.20 0.020
Serum creatinine, umol/L (Q1-Q3) 83 (67-112) 74 (59-106) 0.83 87 (75-105) 83 (70-103) 0.88 0.40
GFR, ml/min/1.73 m2 (Q1-Q3) 63 (44-84) 74 (46-96) 0.04 81 (65-96) 82 (65-104) 0.30 <0.0001
GRACE risk score, points (Q1-Q3) 133 (112-155) 119 (104-143) 0.004 115 (98-136) 112 (90-130) 0.12 <0.0001
CRUSADE risk score, points (Q1-Q3) 41 (32-51) 34 (26-49) 0.17 22 (15-34) 20 (14-29) 0.08 <0.0001
LVEF, % (Q1-Q3) 42 (35-48) 45 (40-50) 0.02 40 (30-48) 46 (38-50) <0.0001 0.16
LVEF ≤ 35%, % 25.7 14.8 0.08 38.2 17.9 0.0004 0.071

BMI = body mass index; DBP = diastolic blood pressure; GFR = glomerular filtration rate; GRACE = Global Registry of Acute Coronary Events; LBBB = left bundle branch block; LVEF = left ventricular ejection fraction; RBBB = right bundle branch block; SBP = systolic blood pressure; Q1-Q3 = quartile 1 and quartile 3; SD = standard deviation; WBC = white blood cells.